SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-249748
Filing Date
2022-09-23
Accepted
2022-09-23 09:23:04
Documents
19
Period of Report
2022-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d378568d8k.htm   iXBRL 8-K 42434
2 EX-1.1 d378568dex11.htm EX-1.1 215452
3 EX-4.1 d378568dex41.htm EX-4.1 86522
4 EX-5.1 d378568dex51.htm EX-5.1 15768
5 EX-99.1 d378568dex991.htm EX-99.1 9040
9 GRAPHIC g378568dsp19aa.jpg GRAPHIC 4150
10 GRAPHIC g378568dsp19b.jpg GRAPHIC 17482
11 GRAPHIC g378568g0923102805457.jpg GRAPHIC 4717
  Complete submission text file 0001193125-22-249748.txt   627132

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA trvi-20220922.xsd EX-101.SCH 2887
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvi-20220922_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvi-20220922_pre.xml EX-101.PRE 11728
13 EXTRACTED XBRL INSTANCE DOCUMENT d378568d8k_htm.xml XML 3469
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38886 | Film No.: 221260786
SIC: 2834 Pharmaceutical Preparations